Relationship between 24 h blood pressure variability and mortality in acute myocardial infarction patients
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Ying Liu, Wen Li, Shuoyan An, Zhengqin Zhai, Xinju Liu, Mengxue Hei, Gailing Chen |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
QRS fragmentation does not predict mortality in survivors of acute myocardial infarction
by: Julia Allescher, et al.
Published: (2024)
by: Julia Allescher, et al.
Published: (2024)
The CRP troponin test (CTT) stratifies mortality risk in patients with non‐ST elevation myocardial infarction (NSTEMI)
by: Rafael Y. Brzezinski, et al.
Published: (2024)
by: Rafael Y. Brzezinski, et al.
Published: (2024)
Incorporating multiple biomarkers to assess mortality risk in non‐ST elevation myocardial infarction
by: William Laband, et al.
Published: (2024)
by: William Laband, et al.
Published: (2024)
Interdialytic home systolic blood pressure variability increases all‐cause mortality in hemodialysis patients
by: Liping Dong, et al.
Published: (2024)
by: Liping Dong, et al.
Published: (2024)
Establishment and validation of a prediction model for nonrecovery of left ventricular ejection fraction in acute myocardial infarction patients combined with decreased left ventricular ejection fraction
by: Yang Yang, et al.
Published: (2024)
by: Yang Yang, et al.
Published: (2024)
Elevated uric acid/albumin ratio as a predictor of poor coronary collateral circulation development in patients with non‐ST segment elevation myocardial infarction
by: Renlin Yin, et al.
Published: (2024)
by: Renlin Yin, et al.
Published: (2024)
The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis
by: LinLi Wang, et al.
Published: (2024)
by: LinLi Wang, et al.
Published: (2024)
Time‐weighted blood pressure with cardiovascular risk among patients with or without diabetes
by: Zhixin Jiang, et al.
Published: (2024)
by: Zhixin Jiang, et al.
Published: (2024)
Prognostic significance of IL‐18 in acute coronary syndrome patients
by: Chenchun Xiong, et al.
Published: (2024)
by: Chenchun Xiong, et al.
Published: (2024)
Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease
by: Zhuoyan Zhao, et al.
Published: (2024)
by: Zhuoyan Zhao, et al.
Published: (2024)
Safety of ultra‐low contrast coronary angiography in patients with acute kidney injury
by: Zach Rozenbaum, et al.
Published: (2024)
by: Zach Rozenbaum, et al.
Published: (2024)
A higher non‐HDL‐C/HDL‐C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Jiamin Liu, et al.
Published: (2024)
by: Jiamin Liu, et al.
Published: (2024)
Predicting the risk of mortality and rehospitalization in heart failure patients: A retrospective cohort study by machine learning approach
by: Marzieh Ketabi, et al.
Published: (2024)
by: Marzieh Ketabi, et al.
Published: (2024)
Predicting the risk of mortality and rehospitalization in heart failure patients: A retrospective cohort study by machine learning approach
by: Reza Tabrizi, et al.
Published: (2024)
by: Reza Tabrizi, et al.
Published: (2024)
An association between heart rate variability and incident heart failure in an elderly cohort
by: Bozena Ostrowska, et al.
Published: (2024)
by: Bozena Ostrowska, et al.
Published: (2024)
Lactate dehydrogenase‐to‐albumin ratio: A superior inflammatory marker for predicting contrast‐associated acute kidney injury after percutaneous coronary intervention
by: Ji‐Lang Zeng, et al.
Published: (2024)
by: Ji‐Lang Zeng, et al.
Published: (2024)
Incidence of chemotherapy‐related cardiac dysfunction in cancer patients
by: Hai‐Wei Deng, et al.
Published: (2024)
by: Hai‐Wei Deng, et al.
Published: (2024)
Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study
by: Shiyue Zheng, et al.
Published: (2024)
by: Shiyue Zheng, et al.
Published: (2024)
Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
by: Jee‐Heon Kim, et al.
Published: (2024)
by: Jee‐Heon Kim, et al.
Published: (2024)
Comparison between beta‐blockers and calcium channel blockers in patients with atrial fibrillation according to renal function
by: José Antonio Parada Barcia, et al.
Published: (2024)
by: José Antonio Parada Barcia, et al.
Published: (2024)
A Novel Clinical Score Integrating Low‐Voltage Zones and Biomarkers Predicts Atrial Fibrillation Recurrence Post‐Ablation
by: Ying Han, et al.
Published: (2025)
by: Ying Han, et al.
Published: (2025)
Impact of Walking and Respiratory Training on Cardiopulmonary Function and Activity Endurance in Patients With Chronic Heart Failure
by: Qiu‐Chen Wang, et al.
Published: (2025)
by: Qiu‐Chen Wang, et al.
Published: (2025)
Comment on “Association of kidney disease index with all‐cause and cardiovascular mortality among individuals with hypertension”
by: Tomoyuki Kawada
Published: (2024)
by: Tomoyuki Kawada
Published: (2024)
Prediabetes and major adverse cardiac events after acute coronary syndrome: An overestimated concept
by: Amir Hossein Behnoush, et al.
Published: (2024)
by: Amir Hossein Behnoush, et al.
Published: (2024)
The involvement of circulating miR‐146a and miR‐27a in patients with atherosclerotic cardiovascular disease after SARS‐CoV‐2 infection
by: Jiahong Zhou, et al.
Published: (2024)
by: Jiahong Zhou, et al.
Published: (2024)
A Predictive Nomogram of In‐Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit
by: Wenhui Wang, et al.
Published: (2024)
by: Wenhui Wang, et al.
Published: (2024)
China Elite Athletes Cardiovascular hEath (China‐ACE) Study: A Protocol for a Multicenter Prospective Cohort
by: Sheng Xu, et al.
Published: (2025)
by: Sheng Xu, et al.
Published: (2025)
The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunction
by: Robert A. Kloner, et al.
Published: (2024)
by: Robert A. Kloner, et al.
Published: (2024)
Anticoagulant Impact on Clinical Outcomes of Pulmonary Embolism Compared With Thrombolytic Therapy; Meta‐Analysis
by: Yang Su, et al.
Published: (2024)
by: Yang Su, et al.
Published: (2024)
The Relationship Between Ambulatory Arterial Stiffness Index and Incident Atrial Fibrillation
by: Christopher Boos
Published: (2024)
by: Christopher Boos
Published: (2024)
The prognostic value of the visually assessed time difference between mitral valve and tricuspid valve opening score for patients with heart failure with mildly reduced ejection fraction
by: Yin Yue, et al.
Published: (2024)
by: Yin Yue, et al.
Published: (2024)
Comment on “The Relationship Between Ambulatory Arterial Stiffness Index and Incident Atrial Fibrillation”
by: Mustafa Candemir, et al.
Published: (2024)
by: Mustafa Candemir, et al.
Published: (2024)
Right Heart Contrast Echocardiography Microbubble Count and Migraine Severity: A Dose–Effect Relationship Study
by: Haijuan Gu, et al.
Published: (2025)
by: Haijuan Gu, et al.
Published: (2025)
Relationship Between Left Ventricular Ejection Fraction and ICD‐10 Codes Among Patients Hospitalized With Heart Failure
by: Ty J. Gluckman, et al.
Published: (2024)
by: Ty J. Gluckman, et al.
Published: (2024)
Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In‐Stent Restenosis
by: Botao Zhao, et al.
Published: (2026)
by: Botao Zhao, et al.
Published: (2026)
Risk of supranormal left ventricular ejection fraction in patients with aortic stenosis
by: Naoya Inoue, et al.
Published: (2024)
by: Naoya Inoue, et al.
Published: (2024)
Investigating Left Atrial Diameter and Heart Failure Onset in Middle‐Aged and Elderly: A Retrospective‐Prospective Study
by: Ai Wang, et al.
Published: (2025)
by: Ai Wang, et al.
Published: (2025)
Interaction of left ventricular size with the outcome of cardiac resynchronization therapy in Japanese patients
by: Ryo Ito, et al.
Published: (2024)
by: Ryo Ito, et al.
Published: (2024)
Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity
by: Ayesha Rehman, et al.
Published: (2024)
by: Ayesha Rehman, et al.
Published: (2024)
Comment on: Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients
by: Vadim Zakiev, et al.
Published: (2024)
by: Vadim Zakiev, et al.
Published: (2024)
Similar Items
-
QRS fragmentation does not predict mortality in survivors of acute myocardial infarction
by: Julia Allescher, et al.
Published: (2024) -
The CRP troponin test (CTT) stratifies mortality risk in patients with non‐ST elevation myocardial infarction (NSTEMI)
by: Rafael Y. Brzezinski, et al.
Published: (2024) -
Incorporating multiple biomarkers to assess mortality risk in non‐ST elevation myocardial infarction
by: William Laband, et al.
Published: (2024) -
Interdialytic home systolic blood pressure variability increases all‐cause mortality in hemodialysis patients
by: Liping Dong, et al.
Published: (2024) -
Establishment and validation of a prediction model for nonrecovery of left ventricular ejection fraction in acute myocardial infarction patients combined with decreased left ventricular ejection fraction
by: Yang Yang, et al.
Published: (2024)